BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22331691)

  • 1. The efficacy of in-and-out catheterization as a way of trial without catheterization strategy for treatment of acute urinary retention induced by benign prostate hyperplasia: variables predicting success outcome.
    Ko YH; Kim JW; Kang SG; Jang HA; Kang SH; Park HS; Moon du G; Cheon J; Kim JJ; Lee JG
    Neurourol Urodyn; 2012 Apr; 31(4):460-4. PubMed ID: 22331691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
    Zhengyong Y; Changxiao H; Shibing Y; Caiwen W
    Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia.
    Bhomi KK; Bhattachan CL
    Nepal Med Coll J; 2011 Sep; 13(3):178-81. PubMed ID: 22808810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Reten-World survey of the management of acute urinary retention: preliminary results.
    Emberton M; Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
    Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
    Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.
    Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K;
    BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management outcome of acute urinary retention: model of prediction.
    Daly P; Connolly S; Rogers E; Sweeney P
    Urol Int; 2009; 83(1):39-43. PubMed ID: 19641357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate size influences the outcome after presenting with acute urinary retention.
    McNeill AS; Rizvi S; Byrne DJ
    BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.
    Alan McNeill S
    Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
    McNeill SA; Hargreave TB; Roehrborn CG;
    Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
    Ghalayini IF; Al-Ghazo MA; Pickard RS
    BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis.
    Bansal A; Arora A
    Neurourol Urodyn; 2017 Sep; 36(7):1757-1762. PubMed ID: 28101889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign prostatic hyperplasia: mode of presentation and postoperative outcome.
    Khan M; Khan AL; Khan S; Nawaz H
    J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial).
    Elbendary M; El-Gamal OM; Soliman MG; Tawfik A; Taha MR
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):362-6. PubMed ID: 24018711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of management of patients presenting with acute urinary retention due to benign prostatic hyperplasia: a hospital based study.
    Pandit RK; Agrawal CS; Chalise PR; Sapkota G
    Kathmandu Univ Med J (KUMJ); 2008; 6(24):448-52. PubMed ID: 19483424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of conservatively managed acute urinary retention: prostate size matters.
    Kumar V; Marr C; Bhuvangiri A; Irwin P
    BJU Int; 2000 Nov; 86(7):816-9. PubMed ID: 11069406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of postoperative urinary retention: a randomized trial of in-out versus overnight catheterization.
    Lau H; Lam B
    ANZ J Surg; 2004 Aug; 74(8):658-61. PubMed ID: 15315566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feedback microwave thermotherapy versus TURP/prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, randomized, controlled, multicenter study.
    Schelin S; Geertsen U; Walter S; Spångberg A; Duelund-Jacobsen J; Krøyer K; Hjertberg H; Vatne V; Richthoff J; Nordling J
    Urology; 2006 Oct; 68(4):795-9. PubMed ID: 17070355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention.
    Kumar S; Tiwari DP; Ganesamoni R; Singh SK
    Urology; 2013 Jul; 82(1):171-5. PubMed ID: 23561712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.